These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7241811)

  • 1. [Relationship between Clostridium botulinum type A toxin and theophylline derivatives. I. Effect of theophylline against toxicity of the toxin for mice (author's transl)].
    Sato S; Nagano S; Takaoka E
    Nihon Saikingaku Zasshi; 1980 Mar; 35(2):419-22. PubMed ID: 7241811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extraction and concentration of Clostridium botulinum toxins from specimens (author's transl)].
    Sonnenschein B; Bisping W
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):247-59. PubMed ID: 5836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular construction and biological activities of botulinum toxins (author's transl)].
    Sakaguchi G; Ohishi I
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():45-54. PubMed ID: 800282
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of polyclonal antibodies in mice against cobratoxin, botulinum toxin and ricin without altering their toxicity or use of adjuvant.
    Lipps BV
    J Nat Toxins; 2001 Feb; 10(1):27-32. PubMed ID: 11288726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding and degenerative effect of Clostridium botulinum type A, C and E toxins on cultured neurons].
    Kurokawa Y
    Hokkaido Igaku Zasshi; 1987 May; 62(3):381-91. PubMed ID: 3610033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and toxicity of Clostridium botulinum type C toxin.
    Syuto B; Kubo S
    Jpn J Med Sci Biol; 1979 Apr; 32(2):132-3. PubMed ID: 541872
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptic activation of Clostridium botulinum type C beta toxin.
    Jansen BC; Knoetze PC
    Onderstepoort J Vet Res; 1971 Dec; 38(4):237-8. PubMed ID: 5164858
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes.
    Suzuki JB; Booth RR; Grecz N
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):691-711. PubMed ID: 4944551
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
    Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A
    Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility of broiler chickens to Clostridium botulinum type C toxin.
    Dohms JE; Cloud SS
    Avian Dis; 1982; 26(1):89-96. PubMed ID: 7046722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
    Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
    Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin.
    Nakamura S; Serikawa T; Yamakawa K; Nishida S; Kozaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1979 Apr; 32(2):128-9. PubMed ID: 396395
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations.
    Santos JI; Swensen P; Glasgow LA
    Pediatrics; 1981 Jul; 68(1):50-4. PubMed ID: 7243509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.
    Borodic GE; Ferrante R; Pearce LB; Smith K
    Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of botulinum toxins for lethal toxicity by intravenous injection into mice.
    Kondo H; Shimizu T; Kubonoya M; Izumi N; Takahashi M; Sakaguchi G
    Jpn J Med Sci Biol; 1984 Jun; 37(3):131-5. PubMed ID: 6503025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.